Stocktoria
Liminatus Pharma, Inc. LIMN
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-05-18
Liminatus Pharma, Inc. statistics & valuation
Market cap$5.3M
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 |
|---|---|---|
| Return on assets | -1990.4% | -65.6% |
| Return on equity | 104.0% | 18.3% |
| Current ratio | 0.05 | 0.21 |
Source: SEC EDGAR filings · CIK 0001971387 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.